Skip to main content
Erschienen in: International Ophthalmology 4/2018

10.07.2017 | Original Paper

Macular ganglion cell–inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine

verfasst von: Emrah Kan, Konuralp Yakar, Mehmet Derya Demirag, Mustafa Gok

Erschienen in: International Ophthalmology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study evaluated the macular ganglion cell–inner plexiform layer (GC-IPL) thickness using spectral-domain (SD) optical coherence tomography (OCT) in patients with chronic exposure to hydroxychloroquine (HCQ).

Methods

A total of 90 patients (90 eyes) treated with HCQ for at least 5 years and normal controls were included in the study. A fundus examination, automated threshold perimetry, and GC-IPL thickness measurements using the Cirrus high-definition OCT ganglion cell analysis algorithm were performed in all patients treated with HCQ. Average, minimum, and sectorial macular GC-IPL thicknesses were compared between the patients and controls.

Results

There was no statistically significant difference in age or sex between the groups. The anterior segment and fundoscopy were normal in all patients and controls. Visual field (VF) testing was normal in all patients. The average, minimum, and sectorial macular GC-IPL thicknesses were significantly lower in patients than those in control subjects.

Conclusions

There was significant thinning of the macular GC-IPL in the absence of clinically evident HCQ-related retinopathy and VF abnormalities. Measurements of the macular GC-IPL thickness using SD-OCT may therefore be useful in the early diagnosis and in monitoring the progression of retinal changes in patients receiving long-term HCQ therapy.
Literatur
1.
Zurück zum Zitat Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 110:1321–1326CrossRefPubMed Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 110:1321–1326CrossRefPubMed
2.
Zurück zum Zitat Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703–2706PubMed Bienfang D, Coblyn JS, Liang MH, Corzillius M (2000) Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series. J Rheumatol 27:2703–2706PubMed
3.
Zurück zum Zitat Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T (1997) Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice. Arthritis Rheum 40:1482–1486CrossRefPubMed Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T (1997) Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice. Arthritis Rheum 40:1482–1486CrossRefPubMed
4.
Zurück zum Zitat Tzekov R (2005) Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 110:111–120CrossRefPubMed Tzekov R (2005) Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 110:111–120CrossRefPubMed
5.
Zurück zum Zitat Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109:1377–1382CrossRefPubMed Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109:1377–1382CrossRefPubMed
6.
Zurück zum Zitat Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57CrossRefPubMed Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57CrossRefPubMed
7.
Zurück zum Zitat Carr RE, Gouras P, Gunkel RD (1966) Chloroquine retinopathy: early detection by retinal threshold test. Arch Ophthalmol 75:171–178CrossRefPubMed Carr RE, Gouras P, Gunkel RD (1966) Chloroquine retinopathy: early detection by retinal threshold test. Arch Ophthalmol 75:171–178CrossRefPubMed
8.
Zurück zum Zitat Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Choroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175PubMed Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Choroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175PubMed
9.
Zurück zum Zitat Hallberg A, Naeser P, Andersson A (1990) Effects of long-term chloroquine exposure on the phospholipids metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 68:125–130CrossRef Hallberg A, Naeser P, Andersson A (1990) Effects of long-term chloroquine exposure on the phospholipids metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 68:125–130CrossRef
10.
Zurück zum Zitat Easterbrook M (1992) Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 27:237–239PubMed Easterbrook M (1992) Long-term course of antimalarial maculopathy after cessation of treatment. Can J Ophthalmol 27:237–239PubMed
11.
Zurück zum Zitat Michaelides M, Stover NB, Francis PJ, Weleber RG (2011) Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol 129:30–39CrossRefPubMed Michaelides M, Stover NB, Francis PJ, Weleber RG (2011) Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol 129:30–39CrossRefPubMed
12.
Zurück zum Zitat Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA (2013) Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol 131:1187–1197CrossRefPubMed Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA (2013) Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol 131:1187–1197CrossRefPubMed
13.
Zurück zum Zitat Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422CrossRefPubMed Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:415–422CrossRefPubMed
14.
Zurück zum Zitat Gonasum LM, Potts AM (1974) In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol Vis Sci 13:107–115 Gonasum LM, Potts AM (1974) In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol Vis Sci 13:107–115
15.
Zurück zum Zitat Geamănu Pancă A, Popa-Cherecheanu A, Marinescu B, Geamănu CD, Voinea LM (2014) Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. J Med Life 7:322–326PubMedPubMedCentral Geamănu Pancă A, Popa-Cherecheanu A, Marinescu B, Geamănu CD, Voinea LM (2014) Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. J Med Life 7:322–326PubMedPubMedCentral
16.
Zurück zum Zitat Palma Sánchez D, Rubio Velazquez E, Soro Marín S, Reyes García R (2013) Retinal toxicity due to antimalarials: frequency and risk factors. Reumatol Clin 9:259–262CrossRefPubMed Palma Sánchez D, Rubio Velazquez E, Soro Marín S, Reyes García R (2013) Retinal toxicity due to antimalarials: frequency and risk factors. Reumatol Clin 9:259–262CrossRefPubMed
17.
Zurück zum Zitat Wolfe F, Marmor MF (2010) Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:775–784CrossRef Wolfe F, Marmor MF (2010) Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62:775–784CrossRef
18.
Zurück zum Zitat Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim CY (2010) Structure function relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci 51:4646–4651CrossRefPubMed Kim NR, Lee ES, Seong GJ, Kim JH, An HG, Kim CY (2010) Structure function relationship and diagnostic value of macular ganglion cell complex measurement using Fourier-domain OCT in glaucoma. Invest Ophthalmol Vis Sci 51:4646–4651CrossRefPubMed
19.
Zurück zum Zitat Cho JW, Sung KR, Lee S, Yun SC, Kang SY, Choi J et al (2010) Relationship between visual field sensitivity and macular ganglion cell complex thickness as measured by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 51:6401–6407CrossRefPubMed Cho JW, Sung KR, Lee S, Yun SC, Kang SY, Choi J et al (2010) Relationship between visual field sensitivity and macular ganglion cell complex thickness as measured by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 51:6401–6407CrossRefPubMed
20.
Zurück zum Zitat Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ (2011) Macular ganglion cell–inner plexiform layer: automated detection and thickness reproducibility with spectral domain–optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci 52:8323–8329CrossRefPubMedPubMedCentral Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ (2011) Macular ganglion cell–inner plexiform layer: automated detection and thickness reproducibility with spectral domain–optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci 52:8323–8329CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Girkin CA, McGwin G Jr, Sinai MJ, Sekhar GC, Fingeret M et al (2011) Variation in optic nerve and macular structure with age and race with spectraldomain optical coherence tomography. Ophthalmology 118:2403–2408CrossRefPubMed Girkin CA, McGwin G Jr, Sinai MJ, Sekhar GC, Fingeret M et al (2011) Variation in optic nerve and macular structure with age and race with spectraldomain optical coherence tomography. Ophthalmology 118:2403–2408CrossRefPubMed
22.
Zurück zum Zitat Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF et al (2013) Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma 22:532–541CrossRefPubMed Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF et al (2013) Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma 22:532–541CrossRefPubMed
23.
Zurück zum Zitat Koh VT, Tham YC, Cheung CY, Wong WL, Baskaran M, Saw SM, Wong TY, Aung T (2012) Determinants of ganglion cell–inner plexiform layer thickness measured by high-definition optical coherence tomography. Invest Ophthalmol Vis Sci 53:5853–5859CrossRefPubMed Koh VT, Tham YC, Cheung CY, Wong WL, Baskaran M, Saw SM, Wong TY, Aung T (2012) Determinants of ganglion cell–inner plexiform layer thickness measured by high-definition optical coherence tomography. Invest Ophthalmol Vis Sci 53:5853–5859CrossRefPubMed
24.
Zurück zum Zitat Bonanomi MT, Dantas NC, Medeiros FA (2006) Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Experiment Ophthalmol 34:130–136CrossRefPubMed Bonanomi MT, Dantas NC, Medeiros FA (2006) Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Experiment Ophthalmol 34:130–136CrossRefPubMed
25.
Zurück zum Zitat Pasadhika S, Fishman GA (2010) Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond) 24:340–346CrossRef Pasadhika S, Fishman GA (2010) Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond) 24:340–346CrossRef
26.
Zurück zum Zitat Ulviye Y, Betul T, Nur TH, Selda C (2013) Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine. Indian J Ophthalmol 61(4):168–171CrossRefPubMedPubMedCentral Ulviye Y, Betul T, Nur TH, Selda C (2013) Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine. Indian J Ophthalmol 61(4):168–171CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J et al (2014) Macular retinal ganglion cell–inner plexiform layer thickness in patients on hydroxychloroquine therapy. Invest Ophthalmol Vis Sci 25(56):396–402 Lee MG, Kim SJ, Ham DI, Kang SW, Kee C, Lee J et al (2014) Macular retinal ganglion cell–inner plexiform layer thickness in patients on hydroxychloroquine therapy. Invest Ophthalmol Vis Sci 25(56):396–402
28.
Zurück zum Zitat Pasadhika S, Fishman GA, Choi D, Shahidi M (2010) Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond) 245:756–762CrossRef Pasadhika S, Fishman GA, Choi D, Shahidi M (2010) Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye (Lond) 245:756–762CrossRef
29.
Zurück zum Zitat Marmor MF, Melles RB (2014) Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 121:1257–1262CrossRefPubMed Marmor MF, Melles RB (2014) Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Ophthalmology 121:1257–1262CrossRefPubMed
30.
Zurück zum Zitat Uslu H, Gurler B, Yildirim A, Tatar MG, Aylin Kantarcı F, Goker H, Pehlevan HS, Colak HN (2016) Effect of hydroxychloroquine on the retinal layers: a quantitative evaluation with spectral-domain optical coherence tomography. J Ophthalmol 2016:8643174. doi:10.1155/2016/8643174 CrossRefPubMedPubMedCentral Uslu H, Gurler B, Yildirim A, Tatar MG, Aylin Kantarcı F, Goker H, Pehlevan HS, Colak HN (2016) Effect of hydroxychloroquine on the retinal layers: a quantitative evaluation with spectral-domain optical coherence tomography. J Ophthalmol 2016:8643174. doi:10.​1155/​2016/​8643174 CrossRefPubMedPubMedCentral
Metadaten
Titel
Macular ganglion cell–inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine
verfasst von
Emrah Kan
Konuralp Yakar
Mehmet Derya Demirag
Mustafa Gok
Publikationsdatum
10.07.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 4/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0635-y

Weitere Artikel der Ausgabe 4/2018

International Ophthalmology 4/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.